Related Experiment Video
Updated: Jun 5, 2026
Refined Murine Model of Idiopathic Pulmonary Fibrosis
Published on: June 17, 2025
TSP-1 in lung fibrosis
1Medical Sciences Building, University of Western Ontario, London, ON N6A 5C1 Canada.
Abstract:
Lung fibrosis is often treated with corticosteroids to reduce the inflammatory response, however, no effective treatment options exist for the underlying disease. An important player in the fibrotic cascade is the cytokine, transforming growth factor beta (TGFβ). TGFβ is converted from an inactive procytokine complex to active TGFβ by enzymes such as thrombospondin-1 (TSP-1). It is therefore presumed that TSP-1 deficient mice would fare better to bleomycin-induced pulmonary fibrosis because TGFβ would not be efficiently converted to the active form. Interestingly, a recent article by Ezzie and colleagues shows that TSP-1 deficiency does not protect mice from systemic bleomycin challenge. Indeed, they find the opposite, as TSP-1-null mice appear to exhibit greater lung fibrosis than wild type mice, although similar TGFβ signaling was observed in the lungs of both mouse strains.
Insights
Thrombospondin-1 (TSP-1) deficiency surprisingly worsens lung fibrosis in mice, contrary to expectations. TSP-1-null mice showed increased fibrosis after bleomycin challenge, despite similar TGFβ signaling.
Area of Science:
- Pulmonary Medicine
- Fibrosis Research
- Immunology
Background:
- Lung fibrosis lacks effective treatments beyond managing inflammation.
- Transforming growth factor beta (TGFβ) is a key cytokine in fibrotic processes.
- Thrombospondin-1 (TSP-1) activates TGFβ, suggesting TSP-1 deficiency might be protective.
Purpose of the Study:
- To investigate the role of TSP-1 in bleomycin-induced lung fibrosis.
- To determine if TSP-1 deficiency protects mice from pulmonary fibrosis.
Main Methods:
- Bleomycin-induced lung fibrosis model in TSP-1 deficient mice and wild-type controls.
- Assessment of lung fibrosis severity.
- Analysis of TGFβ signaling pathways.
Main Results:
- TSP-1 deficient mice exhibited exacerbated lung fibrosis compared to wild-type mice.
- No significant difference in TGFβ signaling was observed between TSP-1 deficient and wild-type mice.
- Contrary to hypothesis, TSP-1 deficiency did not protect against bleomycin-induced pulmonary fibrosis.
Conclusions:
- TSP-1 deficiency exacerbates, rather than protects against, bleomycin-induced lung fibrosis.
- The role of TSP-1 in pulmonary fibrosis is complex and warrants further investigation.
- Novel therapeutic targets for lung fibrosis may need to consider TSP-1's multifaceted functions.
